Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling
暂无分享,去创建一个
C. Rosano | M. Maggiolini | R. Lappano | A. Cappello | P. Marco | D. Rigiracciolo | S. Avino | P. D. Marco | Ernestina Marianna De Francesco | Silvia Avino
[1] A. Vivacqua,et al. The G protein estrogen receptor (GPER) is regulated by endothelin-1 mediated signaling in cancer cells. , 2016, Cellular signalling.
[2] B. Bussolati,et al. GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells , 2015, Oncotarget.
[3] M. Maggiolini,et al. Pregnancy Augments G Protein Estrogen Receptor (GPER) Induced Vasodilation in Rat Uterine Arteries via the Nitric Oxide - cGMP Signaling Pathway , 2015, PloS one.
[4] A. Belfiore,et al. Copper activates HIF-1α/GPER/VEGF signalling in cancer cells , 2015, Oncotarget.
[5] P. Ratcliffe,et al. HIF hydroxylase pathways in cardiovascular physiology and medicine. , 2015, Circulation research.
[6] D. Aebersold,et al. Interplay between receptor tyrosine kinases and hypoxia signaling in cancer. , 2015, The international journal of biochemistry & cell biology.
[7] W. Xiang,et al. Activation of novel estrogen receptor GPER results in inhibition of cardiocyte apoptosis and cardioprotection , 2015, Molecular medicine reports.
[8] H. Feng,et al. G-protein-coupled receptor 30-mediated antiapoptotic effect of estrogen on spinal motor neurons following injury and its underlying mechanisms , 2015, Molecular medicine reports.
[9] E. D. du Toit,et al. Opioid receptors and cardioprotection – ‘opioidergic conditioning’ of the heart , 2015, British journal of pharmacology.
[10] E. Prossnitz,et al. Effects of Atrazine on Estrogen Receptor α– and G Protein–Coupled Receptor 30–Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts , 2015, Environmental health perspectives.
[11] F. Spinella,et al. Endothelin-1 regulates hypoxia-inducible factor-1α and -2α stability through prolyl hydroxylase domain 2 inhibition in human lymphatic endothelial cells. , 2014, Life sciences.
[12] A. Belfiore,et al. GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts. , 2014, Endocrine-related cancer.
[13] Zhuojia Chen,et al. The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo , 2014, Cell Death and Disease.
[14] H. Chander,et al. Abstract 4053: Formin-binding protein-17 (FBP17) is a target of p53 and promotes invadopodia formation in breast cancer cells , 2014 .
[15] E. Prossnitz,et al. G Protein–Coupled Estrogen Receptor Regulates Mammary Tumorigenesis and Metastasis , 2014, Molecular Cancer Research.
[16] S. Rho,et al. The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression , 2014, Oncotarget.
[17] M. Pellegrino,et al. GPER mediates activation of HIF1α/VEGF signaling by estrogens. , 2014, Cancer research.
[18] M. Maggiolini,et al. GPER Function in Breast Cancer: An Overview , 2014, Front. Endocrinol..
[19] M. Fernö,et al. Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer , 2014, Breast Cancer Research and Treatment.
[20] M. Wu,et al. Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells , 2014, Oncogene.
[21] Haien Zhao,et al. Hypoxia Promotes Migration and Induces CXCR4 Expression via HIF-1α Activation in Human Osteosarcoma , 2014, PloS one.
[22] Z. Ignatova,et al. GPER functions as a tumor suppressor in triple-negative breast cancer cells , 2014, Journal of Cancer Research and Clinical Oncology.
[23] Christine Weissenborn,et al. GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells , 2014, Journal of Cancer Research and Clinical Oncology.
[24] G. Dorn,et al. Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2. , 2013, The Journal of clinical investigation.
[25] V. Conti,et al. Adrenergic signaling and oxidative stress: a role for sirtuins? , 2013, Front. Physiol..
[26] Stephen Henderson,et al. The G-Protein–Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis , 2013, Clinical Cancer Research.
[27] M. Maggiolini,et al. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) , 2013, Breast Cancer Research.
[28] M. Maggiolini,et al. GPER Mediates Cardiotropic Effects in Spontaneously Hypertensive Rat Hearts , 2013, PloS one.
[29] P. Bagnoli,et al. Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization , 2013, Journal of Molecular Medicine.
[30] D. Dang,et al. Regulation of Hypoxia-inducible Factor 1α (HIF-1α) by Lysophosphatidic Acid Is Dependent on Interplay between p53 and Krüppel-like Factor 5* , 2013, The Journal of Biological Chemistry.
[31] C. Huang,et al. β2-AR-HIF-1α: a novel regulatory axis for stress-induced pancreatic tumor growth and angiogenesis. , 2013, Current molecular medicine.
[32] A. Roessner,et al. GPER-1 Expression Decreases During Breast Cancer Tumorigenesis , 2013, Cancer investigation.
[33] R. Dacey,et al. G Protein–Coupled Estrogen Receptor Agonist Improves Cerebral Microvascular Function After Hypoxia/Reoxygenation Injury in Male and Female Rats , 2013, Stroke.
[34] A. Belfiore,et al. Insulin-like growth factor-I regulates GPER expression and function in cancer cells , 2013, Oncogene.
[35] V. Farini,et al. β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines , 2013, Laboratory Investigation.
[36] Sung-Chun Tang,et al. Stroke Increases G Protein-Coupled Estrogen Receptor Expression in the Brain of Male but Not Female Mice , 2012, Neurosignals.
[37] A. Belfiore,et al. New advances on the functional cross-talk between insulin-like growth factor-I and estrogen signaling in cancer. , 2012, Cellular signalling.
[38] F. Otterbach,et al. New Insight into the SDF-1/CXCR4 Axis in a Breast Carcinoma Model: Hypoxia-Induced Endothelial SDF-1 and Tumor Cell CXCR4 Are Required for Tumor Cell Intravasation , 2012, Molecular Cancer Research.
[39] C. Rosano,et al. Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts , 2012, Environmental health perspectives.
[40] G. Semenza. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. , 2012, Trends in pharmacological sciences.
[41] Kyeong Lee,et al. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. , 2012, European journal of medicinal chemistry.
[42] W. Chai,et al. Hypoxic preconditioning attenuates global cerebral ischemic injury following asphyxial cardiac arrest through regulation of delta opioid receptor system , 2012, Neuroscience.
[43] E. Prossnitz,et al. GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure. , 2011, Immunology, endocrine & metabolic agents in medicinal chemistry.
[44] E. Prossnitz,et al. The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. , 2011, Vascular pharmacology.
[45] A. Roessner,et al. G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer , 2011, Breast Cancer Research and Treatment.
[46] S. Andò,et al. The G Protein-coupled Receptor 30 Is Up-regulated by Hypoxia-inducible Factor-1α (HIF-1α) in Breast Cancer Cells and Cardiomyocytes* , 2011, The Journal of Biological Chemistry.
[47] K. Miyazono,et al. LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. , 2010, Blood.
[48] H. Randeva,et al. G-protein coupled estrogen receptor 1 expression in rat and human heart: Protective role during ischaemic stress. , 2010, International journal of molecular medicine.
[49] D. Meldrum,et al. Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury. , 2010, Surgery.
[50] N. Joste,et al. GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer , 2010, Breast Cancer Research and Treatment.
[51] A. Molinolo,et al. Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma , 2010, Proceedings of the National Academy of Sciences.
[52] M. Maggiolini,et al. Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. , 2010, Cancer research.
[53] G. Czibik. Complex role of the HIF system in cardiovascular biology , 2010, Journal of Molecular Medicine.
[54] C. Rosano,et al. Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells , 2010, Molecular and Cellular Endocrinology.
[55] Bing Zhang,et al. Estradiol and G1 Reduce Infarct Size and Improve Immunosuppression after Experimental Stroke , 2010, The Journal of Immunology.
[56] E. Murphy,et al. Estrogen receptor activation and cardioprotection in ischemia reperfusion injury. , 2010, Trends in cardiovascular medicine.
[57] Tudor I. Oprea,et al. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. , 2010, Cancer research.
[58] M. Maggiolini,et al. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. , 2010, The Journal of endocrinology.
[59] E. Murphy,et al. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. , 2009, American journal of physiology. Heart and circulatory physiology.
[60] S. Fuqua,et al. G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells. , 2009, Molecular endocrinology.
[61] Gerhard Christofori,et al. The angiogenic switch in carcinogenesis. , 2009, Seminars in cancer biology.
[62] N. Joste,et al. GPR30 predicts poor survival for ovarian cancer. , 2009, Gynecologic oncology.
[63] M. Chappell,et al. Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. , 2009, Endocrinology.
[64] S. Rasmussen,et al. The structure and function of G-protein-coupled receptors , 2009, Nature.
[65] Didier Picard,et al. Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF , 2009, The EMBO journal.
[66] S. Andò,et al. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. , 2008, Endocrinology.
[67] John Ross,et al. Myocardial expression, signaling, and function of GPR22: a protective role for an orphan G protein-coupled receptor. , 2008, American journal of physiology. Heart and circulatory physiology.
[68] R. Glaser,et al. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression , 2008, Brain, Behavior, and Immunity.
[69] Tudor I. Oprea,et al. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. , 2007, The Journal of endocrinology.
[70] Meenakshi Singh,et al. GPR30: a novel indicator of poor survival for endometrial carcinoma. , 2007, American journal of obstetrics and gynecology.
[71] J. Gutkind,et al. G-protein-coupled receptors and cancer , 2007, Nature Reviews Cancer.
[72] D. Giri,et al. Distribution of GPR30, a Seven Membrane–Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression , 2006, Clinical Cancer Research.
[73] G. Brewer. Anticopper therapy against cancer and diseases of inflammation and fibrosis. , 2005, Drug discovery today.
[74] M. Miyasaka,et al. Chemokines in tumor progression and metastasis , 2005, Cancer science.
[75] M. Burdick,et al. Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer. , 2005, Cancer research.
[76] G. Semenza,et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. , 2005, Blood.
[77] S. Andò,et al. The G Protein-coupled Receptor GPR30 Mediates c-fos Up-regulation by 17β-Estradiol and Phytoestrogens in Breast Cancer Cells* , 2004, Journal of Biological Chemistry.
[78] L. Devi,et al. Functional interactions between mu opioid and alpha 2A-adrenergic receptors. , 2003, Molecular pharmacology.
[79] R. Bicknell,et al. The FASEB Journal express article 10.1096/fj.02-0993fje. Published online June 17, 2003. Transcriptional regulation of the CRLR gene in human microvascular endothelial cells by hypoxia , 2022 .
[80] D. Mukhopadhyay,et al. Heterotrimeric Gαq/Gα11 Proteins Function Upstream of Vascular Endothelial Growth Factor (VEGF) Receptor-2 (KDR) Phosphorylation in Vascular Permeability Factor/VEGF Signaling* , 2003, Journal of Biological Chemistry.
[81] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[82] S. Rafii,et al. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. , 2003, Cancer cell.
[83] F. Spinella,et al. Endothelin-1 Induces Vascular Endothelial Growth Factor by Increasing Hypoxia-inducible Factor-1α in Ovarian Carcinoma Cells* , 2002, The Journal of Biological Chemistry.
[84] K. Webster,et al. Molecular Regulation of the Endothelin-1 Gene by Hypoxia , 2001, The Journal of Biological Chemistry.
[85] J. Pouysségur,et al. Angiogenesis and G-protein-coupled receptors: signals that bridge the gap , 2001, Oncogene.
[86] J. P. Hobson,et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.
[87] J. Gutkind,et al. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. , 2000, Cancer research.
[88] R. Strieter,et al. CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. , 1998, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[89] G. Semenza,et al. Structural and functional analysis of hypoxia-inducible factor 1. , 1997, Kidney international.
[90] G. Semenza,et al. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[91] M. Maggiolini,et al. G protein-coupled receptors: novel targets for drug discovery in cancer , 2010, Nature Reviews Drug Discovery.
[92] K. Xie,et al. HIF-1α links β-adrenoceptor agonists and pancreatic cancer cells under normoxic condition , 2010, Acta Pharmacologica Sinica.
[93] R. Lefkowitz,et al. Signalling: Seven-transmembrane receptors , 2002, Nature Reviews Molecular Cell Biology.
[94] Adrian L. Harris,et al. Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.
[95] 木村 征靖. Orphan G protein-coupled receptor,GPR41,induces apoptosis via a p53/Bax pathway during ischemic hypoxia and reoxygenation , 2001 .
[96] J. Gutkind,et al. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. , 2000, Cancer research.